Your Health. Your Family. Your Choice.
Life Threatening? Yes
Write-up: Unknown cause of death; Lung embolism; This is a spontaneous report from a non-contactable physician reporting for a patient downloaded from the regulatory authority, company number DE-PEI-202100032178. An 82-year-old female patient received bnt162b2 (COMIRNATY) reported as "mRNA TOZINAMERAN", via an unspecified route of administration on 04Feb2021 (Batch/Lot Number: Unknown) as 0.3 mL, single for covid-19 immunisation, at 82 years old. Medical history included breast cancer from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took COMIRNATY on 07Jan2021 for Prophylactic vaccination. The patient experienced unknown cause of death on an unspecified date and lung embolism on 12Feb2021. The patient underwent lab tests and procedures which included echocardiogram: no results, and Transesophageal echocardiography: no results on unspecified dates. Seriousness criteria was provided as death, hospitalization (unspecified date), and life threatening. The patient died on an unspecified date. It was not reported if an autopsy was performed. Causality was provided as Unclassifiable. No follow-up attempts are possible, information on batch/lot number cannot be obtained.; Reported Cause(s) of Death: Unknown cause of death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166